Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sauter

Showing results (191-200 of 212) with videos related to

Pageof 22
Sort By:
Transboundary and Emerging Diseases|November 1, 2015
Highly Pathogenic Avian Influenza H5N8 in Germany: Outbreak InvestigationsF J Conraths, C Sauter-Louis, A Globig, et al.
Perspectives on Medical Education|May 18, 2026
Self-Monitoring Accuracy over Time for a Complex Diagnostic SkillWolf E Hautz, Thimo Marcin, Stefan K Schauber, et al.
Journal of Negative Results in Biomedicine|July 13, 2016
Age is not associated with intracranial haemorrhage in patients with mild traumatic brain injury and oral anticoagulationThomas C Sauter, Stephan Ziegenhorn, Sufian S Ahmad, et al.
BMJ Open|May 13, 2016
Factors predicting a change in diagnosis in patients hospitalised through the emergency room: a prospective observational studyStefanie C Hautz, Luca Schuler, Juliane E Kämmer, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|May 10, 2019
Diagnostic error increases mortality and length of hospital stay in patients presenting through the emergency roomWolf E Hautz, Juliane E Kämmer, Stefanie C Hautz, et al.
Life (Basel, Switzerland)|July 27, 2022
Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional StudyVepusha Sathanantham, Lorenzo Alberio, Cédric Bovet, et al.
British Journal of Haematology|April 7, 1999
A prospective study of risk-adapted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remissionR A Stahel, L M Jost, T Kroner, et al.
British Journal of Haematology|May 6, 2021
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validationGuido Willekens, Jan-Dirk Studt, Adriana Mendez, et al.
Frontiers in Cardiovascular Medicine|September 27, 2021
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban MeasurementsTamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, et al.
Diagnostics (Basel, Switzerland)|June 28, 2023
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban CalibratorAnnika Burger, Jan-Dirk Studt, Adriana Mendez, et al.
Pageof 22

Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Transboundary and Emerging Diseases|November 1, 2015
Highly Pathogenic Avian Influenza H5N8 in Germany: Outbreak InvestigationsF J Conraths, C Sauter-Louis, A Globig, et al.
Perspectives on Medical Education|May 18, 2026
Self-Monitoring Accuracy over Time for a Complex Diagnostic SkillWolf E Hautz, Thimo Marcin, Stefan K Schauber, et al.
Journal of Negative Results in Biomedicine|July 13, 2016
Age is not associated with intracranial haemorrhage in patients with mild traumatic brain injury and oral anticoagulationThomas C Sauter, Stephan Ziegenhorn, Sufian S Ahmad, et al.
BMJ Open|May 13, 2016
Factors predicting a change in diagnosis in patients hospitalised through the emergency room: a prospective observational studyStefanie C Hautz, Luca Schuler, Juliane E Kämmer, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|May 10, 2019
Diagnostic error increases mortality and length of hospital stay in patients presenting through the emergency roomWolf E Hautz, Juliane E Kämmer, Stefanie C Hautz, et al.
Life (Basel, Switzerland)|July 27, 2022
Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional StudyVepusha Sathanantham, Lorenzo Alberio, Cédric Bovet, et al.
British Journal of Haematology|April 7, 1999
A prospective study of risk-adapted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remissionR A Stahel, L M Jost, T Kroner, et al.
British Journal of Haematology|May 6, 2021
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validationGuido Willekens, Jan-Dirk Studt, Adriana Mendez, et al.
Frontiers in Cardiovascular Medicine|September 27, 2021
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban MeasurementsTamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, et al.
Diagnostics (Basel, Switzerland)|June 28, 2023
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban CalibratorAnnika Burger, Jan-Dirk Studt, Adriana Mendez, et al.
Pageof 22